- HCA Florida hospital names CEO
- How Surgery Partners has grown since 2022: 11 notes
- How eliminating noncompetes could upend the physician power dynamic
- 43.5% of family physicians report burnout as turnover risk rises
- FDA approves Eli Lilly’s GLP-1 pill for weight loss
- CMS requests ACOs apply for LEAD model
- CMS requests ACOs apply for LEAD model
- Henry Ford Health adds medical group
- CMS pilot allows hemp products in care plans: 5 notes
- Closed Illinois hospital owner eyes July reopening
- Closed Illinois hospital owner eyes July reopening
- North Dakota expands medical cache to stabilize supply chain
- Hospitals and gender care for minors: Where things stand
- Michigan practice to close
- Heartland Dental added 5 de novos, 2 affiliations in March
- Surgeon general nomination stalls with no committee vote in sight
- Regulators zero in on hospital contracting
- Regulators zero in on hospital contracting
- Emergency dental office chain adds VideaHealth AI technology
- Dental Care Alliance’s 3-year growth recap: 30+ moves
- Proposed Maine bill would allow optometrists to perform eye surgeries
- Cardiology’s 2026 Match by the numbers
- PDS Health opens practices in California, Virginia
- Supreme Court backs challenge to Colorado conversion therapy ban
- Virginia behavioral health hospital names president
- After Man’s Death Following Insurance Denials, West Virginia Tackles Prior Authorization
- FTC: Evidence too strong to toss USAP antitrust case
- Average tuition for 12 best dental schools in the US
- New York medical society demands physician privileges be protected in Maimonides merger
- 4 hospital, health system layoffs in March
- Texas to lead ibogaine research after pharma proposals fall short
- Advocate plans largest drone delivery network and 2 more supply chain updates
- Hennepin Healthcare warns of closure without legislative funding
- 8 revenue cycle headlines to know from March
- Hundreds of U.S. Hospitals at Risk of Shutting Down From Medicaid Cuts
- Ensemble, Cohere building first RCM-native LLM
- 4 health systems back in the black in 2025
- ‘Our stockholders are the members of our community’: Inside Carilion Clinic’s mission-driven margin strategy
- Honey Almond Cream Cheese, Sold at Einstein Bros. Bagels, Recalled Due To Undeclared Nuts
- Trump Supports Surgeon General Pick Despite Senate Concerns
- Lilly answers Novo's GLP-1 pill with highly anticipated FDA nod for Foundayo
- Supreme Court Blocks Colorado Limits on Therapy for LGBTQ Minors
- Hospital groups call on Congress to refine long-term care hospital payments
- Study Shows BMI Often Gets Your Weight Category Wrong
- Antidepressant, Fluvoxamine, Might Help Long COVID Fatigue, Study Says
- Kinesio Taping’s Benefits in Doubt, Major Evidence Review Finds
- High Sodium Intake May Trigger New Heart Failure
- Home-Delivered Groceries Boost Heart Health In Food Deserts, Study Says
- Nicotine E-Cigarettes Help Smokers Quit, Review Concludes
- Clinicians are burnt out. Peer support can help
- Novo's Wegovy nets cardio nod from UK cost gatekeeper, adding 1M+ eligible patients
- Readers Sound Off on Wage Garnishment, Work Requirements, and More
- Trump’s One Big Beautiful Bill Act Darkens Outlook for Government-Backed Clinics
- CVS Health opens pharmacy-only locations as it rightsizes store footprint
- How Rural Health Systems Are Advancing Cardiac Imaging
- How Rural Health Systems Are Advancing Cardiac Imaging
- Beyond Reimbursement: Why Market Access is MedTech’s Strategic North Star
- Beyond Reimbursement: Why Market Access is MedTech’s Strategic North Star
- Evotec hires exec with AI experience to lead rebooted commercial team
- The Human Side of AI Medical Devices: Why Safety Depends on Design, Not Just Algorithms
- The Human Side of AI Medical Devices: Why Safety Depends on Design, Not Just Algorithms
- Whoop raises $575M series G, Abbott comes on board amid hiring spree
- True ROI of health tech, according to finance leaders
- ‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1
- Where 6 specialty DSOs stand in 2026
- Intermountain joins national trauma, grief network
- Practice closures, new dental schools, DLRs & more: 6 dental updates in New York
- Workforce, patient care, private equity & more: 5 statistics scaring dentists
- American Society of Addiction Medicine updates youth treatment standards
- The shifting oral surgery landscape
- Moody’s upgrades UK King’s Daughters’ credit rating
- Private equity in dentistry has gotten smarter
- Lawmakers introduce child suicide prevention bill
- Bipartisan bill introduced to stabilize physicians' year-to-year pay changes
- UnitedHealthcare launches Avery, a generative AI companion for members
- 14 behavioral health executive moves to know
- Missouri agencies warn of rising nitazene threat
- Only 44% of SUD treatment facilities accept older patients on Medicare: HHS report
- 7 state behavioral health policy updates
- FDA flags serious liver injury cases, 8 deaths with ‘reasonable’ link to Amgen's Tavneos
- Uninsured patients drive nearly 40% of healthcare collections: Cedar survey
- Novo Nordisk cuts 400 roles at troubled Bloomington site
- Former U.S. Surgeon General Challenges Trump Nominee
- Listen to the Latest ‘KFF Health News Minute’
- Iterum initiates wind-down after failure to offload antibiotic with sluggish sales
- Over 10.2 Million Grill Brushes Recalled Over Metal Bristle Risk
- Sex Enhancement Chocolates Recalled Over Hidden Drug Ingredients
- Short Bursts of Exercise Linked To Lower Risk of Major Diseases
- HHS urges hospitals to align patient menus with updated dietary guidance
- Hartford HealthCare, K Health launch PatientGPT, new AI tool to help patients find health information
- Ensemble partners with Cohere to build first RCM-native large language model
- API supplier BASF raises prices up to 20% in response to rising energy, raw material costs
- Biogen, eyeing swift commercial tailwind, ponies up $5.6B for Apellis and its 2 approved meds
- Cold Weather More Deadly For The Heart Than Heat, Study Finds
- Teens' Sleep Patterns Affect Their Diet, Exercise, Study Says
- 'Watch and Wait' Approach Safe For Women With Precancerous Breast Condition, Trial Finds
- Dental Care Can Help Cirrhosis Patients Avoid Liver Cancer, Hospitalization
- Folks With Clogged Arteries Benefit From Aggressively Lower Cholesterol Goal
- Intermittent Fasting Might Help Manage Female Hormone Imbalance, Trial Shows
- Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
- States Pay Deloitte, Others Millions To Comply With Trump Law To Cut Medicaid Rolls
- States pay Deloitte, others millions to comply with Trump law to cut Medicaid rolls
- Employer telehealth company eMed raises $200M at $2B valuation
- Insulet hires Stryker vet, reinstating commercial chief role as C-suite overhaul continues
- FDA extends review of Orca Bio’s novel cell therapy for blood cancers
- Nonprofit Electronic Frontier Foundation sues CMS over AI prior authorization demonstration
- CDRH Guidance: Patient Preference Information (PPI) in Medical Device Decision Making
- CDRH Guidance: Patient Preference Information (PPI) in Medical Device Decision Making
- BSCI’s LAAC CHAMPION-AF study for WATCHMAN FLX meets primary and secondary safety and efficacy endpoints
- BSCI’s LAAC CHAMPION-AF study for WATCHMAN FLX meets primary and secondary safety and efficacy endpoints
- Apple Store to ID Regulated Medical Device Apps
- Apple Store to ID Regulated Medical Device Apps
- CMS: This year's open enrollment brought fewer signups, higher premiums
- Medical Schools No Longer Required To Teach Health Inequities
- Lilly presses for UK deal that would see higher drug prices in exchange for resumed investments: FT
- United plots Tyvaso FDA filing after ph. 3 win elicits talk of 'new IPF standard' and blockbuster sales
- Fluoride Quietly Removed From Birmingham Water Years Ago, Officials Face Backlash
- FDA Weighs Expanding What Can Go Into Supplements
- 9 Now Sickened in Outbreak Tied To Raw Milk and Cheese
- BMS, Novartis, Gilead, Iovance dinged over biologics promos in rare spate of CBER untitled letters
- Nearly half of US hospital markets entirely controlled by 1 or 2 health systems: KFF
- Mental health provider platform Headway acquires team behind AI company Tezi
- Idorsia eyes pediatric insomnia use with midstage trial win for sleep med Quviviq
- Electronic Paperwork Increasing Burnout Risk Among Young Doctors
- Kratom Cases Surging In U.S.
- What Makes Play Fun For Children? Seven Factors Stand Out, Study Says
- Night Shifts Are Tough On People With Type 2 Diabetes, Study Says
- Women's Bone Loss Tied To Heart Health, Study Finds
- Want To Lose Weight? Eat A Boring, Repetitive Diet, Researchers Suggest
- Samsung Biologics union gathers votes to strike as tension over wage, governance mounts
- Takeda begins US layoffs as part of massive $1.3B restructuring
- Biogen looks to shake up SMA status quo with FDA nod for high-dose version of Spinraza
- Inside the High-Stakes Corporate Fight Over Feeding Preterm Babies
- She Owed Her Insurer a Nickel, So It Canceled Her Coverage
- Study Links High Antioxidant Intake To Changes in Offspring Development
- The Healthcare Burnout Backlash (pt 1): Burnout Reaches Well Beyond Clinicians
- The Healthcare Burnout Backlash (pt 1): Burnout Reaches Well Beyond Clinicians
- Even Mild Oxygen Loss in Preemies' First Hours Poses Lifelong Brain Risks: Study
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Providence trims 2025 operating loss to $132M, notches second consecutive quarter of gains
- $3M Verdict Links Social Media to Anxiety and Depression
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Advocate Health to launch ‘nation’s largest’ hospital drone delivery program in Zipline partnership
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
Generic left wing, health care, and pharmaceutical groups are coalescing into a political bloc which vows to derail the nomination of Robert F. Kennedy Jr. as the next Health & Human Services Secretary:
Kennedy opposed by advocates for US health post
By Michael Erman and Julie Steenhuysen - December 16, 2024Summary
* Coalition of 40+ groups opposes Kennedy's HHS nomination
* Groups are concerned about Kennedy's potential vaccine policies
* Advocates target Republican senators to block confirmationDec 16 (Reuters) - An expanding coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top U.S. health job over concerns about his activism against vaccines and other health issues, according to the groups' representatives.
Obamacare advocate Protect Our Care, influential consumer group Public Citizen and Community Catalyst, which fights for equality in healthcare, are part of a coalition of at least 40 organizations targeting a group of Republican U.S. senators to help block Kennedy's confirmation as U.S. Secretary of Health and Human Services.
The Committee to Protect Health Care, a grassroots physician organization, has also amassed nearly 16,000 signatures from physicians who oppose Kennedy's nomination.
The efforts come as Kennedy heads to Capitol Hill to win support following his nomination by President-elect Donald Trump including by meeting with incoming Senate health committee chairman Republican Bill Cassidy, a Cassidy staff member confirmed.
"We’re going to work to block his nomination. And I think we will succeed," said Peter Maybarduk, access to medicines director of Public Citizen, a consumer group founded by Ralph Nader in 1971, which has worked for causes including drug safety and airbags in cars. "Even if RFK Jr. can't amass the power to take down vaccine funding, elevating his falsehoods to some kind of officialdom is a danger all its own."
Kennedy has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades. He disputes the anti-vaccine label and has said he would not prevent Americans from getting inoculations, but is a founder of the anti-vaccine group Children's Health Defense and in a 2023 interview with Lex Fridman said no vaccines are safe and effective.
Kennedy has said he wants to work to end chronic disease, break any ties between employees at the U.S. drugs regulator and industry, and advise U.S. water systems to remove fluoride. Trump has said he will discuss the U.S. childhood vaccination program with Kennedy, and on Monday said all vaccines should be looked at.
Kennedy's spokesperson did not respond to a request for comment. His advocates have said opposition to his nomination stems from corporate interests.
Protect Our Care Executive Director Brad Woodhouse said the group has hired lobbying and advocacy teams in more than six states to try to win over the Republican senators seen as possible "no" votes given their track records on health issues or because they are likely to face strong 2026 reelection challenges.
The groups are also raising money to buy ads and conduct polling on health issues, they said.
Protect Our Care, which works to defend the Affordable Care Act, said it will likely hold media briefings with public health experts and politicians to call attention to Kennedy's policies as he meets with senators.
Others have opposed the nomination as well. Pfizer board member Scott Gottlieb, a former FDA commissioner under Trump, told CNBC last month Kennedy's agenda "will cost lives in this country." The Wall Street Journal's Editorial Board in a Dec. 4 column wrote that Kennedy could "disrupt access to life-saving medicines and the innovation ecosystem that creates them."
HHS has oversight for the FDA, the Centers for Disease Control and Prevention and the National Institutes of Health.
TARGETING SENATORS
Confirmation of Kennedy and other cabinet nominees requires a majority vote in the Senate. Kennedy needs the backing of 50 out of the 53 Republican senators if all 47 Democrats vote against him. The advocates are targeting senators in states including Alaska, Idaho, North Carolina, Iowa, West Virginia and Maine.
American Values 2024, a Super PAC that supports Kennedy, has initiated a video campaign defending the nominee.
In a video it posted on social media platform X, Jay Carson, who used to work for President Bill Clinton and other Democrats but now supports Kennedy, argues that opposition to Kennedy stems from a smear campaign by pharmaceutical companies.
"They're determined to keep him out of Washington, D.C.," the Super PAC said on X.
The top lobby group for drugmakers, Pharmaceutical Research and Manufacturers of America, declined to comment. In a Nov. 14 statement, the industry said it wants to work with the Trump administration.
Community Catalyst, which has raised millions since 1998 to support equal access to healthcare, said Kennedy's anti-vaccine rhetoric and position against fluoridated water pushed it to act.
Mona Shah, Community Catalyst's senior director of policy and strategy, said the group has worked for decades to improve dental care access in hard-to-reach communities that face racial discrimination where removing fluoride from drinking water could do the greatest harm.
"We really feel that some of these policies would hurt communities, really endanger children and families and truly make us sicker as a nation," Shah said.
The Committee to Protect Health Care's petition describes Kennedy's appointment as a threat to patient safety and "an affront" to public health. The group accepts no pharmaceutical industry funding.
Dr. Rob Davidson, the group's executive director and an emergency room physician in Michigan, said Americans need to be aware of Kennedy's "very dangerous" positions on topics like vaccines, and COVID-19 being engineered to target certain racial populations.
"We want to make sure people understand he's not just a kooky guy who says weird things," Davidson said.
More:
https://www.politico.com/live-updates/2024/12/16/congress/rfk-jr-opponents-buy-ads-00194493
RFK Jr. opponents buy ads in key senators’ states
By Daniel Payne - December 16, 2024Opponents of Robert F. Kennedy Jr.’s nomination to lead HHS are buying tens of thousands of dollars in ads across the states of key Republican senators as he plans to meet with them this week.
Protect Our Care, which has launched a Stop RFK War Room, has bought advertising slots — from digital ads to billboards — calling on constituents to urge their senators to oppose Kennedy’s nomination, leaders of the group told POLITICO.
“We’re going to accelerate our activity,” said Brad Woodhouse, executive director of Protect Our Care, a health advocacy group aligned with Democrats. “We think this week’s a big deal.”
The group is targeting GOP senators it believes could be persuaded to vote against Kennedy’s confirmation: Sens. Lisa Murkowski (R-Alaska), Mike Crapo (R-Idaho), Susan Collins (R-Maine), Bill Cassidy (R-La.), Thom Tillis (R-N.C.), Mike Rounds (R-S.D.), John Cornyn (R-Texas), Shelley Moore Capito (R-W.Va.) and the newly elected Jim Justice (R-W.Va.).
The ads connect Kennedy’s unsupported claims about the danger of vaccines to the deaths of more than 80 children during a measles outbreak in Samoa in 2019 — and argue that health professionals, scientists and the conservative Wall Street Journal editorial board oppose his confirmation, making it a safe position for Republicans.
Why it matters: Protect Our Care, along with several groups focused on public health, are arguing to senators — and the public — that Kennedy’s views on vaccines, medical authorities and key health policies would be detrimental to the U.S. population, should he lead HHS.
To block Kennedy, four Republican senators would have to oppose his confirmation if every Democrat votes no.
What’s next? Protect Our Care expects more campaigning against the nominee in the future.
“We will spend more,” Woodhouse said. “We’re just starting this process.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















